44 results on '"Preiss, Jan C."'
Search Results
2. Low Sensitivity of Simtomax Point of Care Test in Detection of Celiac Disease in a Prospective Multicenter Study
3. Improving treatment of patients with inflammatory bowel diseases: a controlled trial of a multifaceted intervention in two German cities
4. Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice—results of a non-representative survey
5. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study
6. Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease
7. Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life
8. Su1544: INTEGRATING THE PATIENT PERSPECTIVE TO VALIDATE A MEASURE OF DISEASE SEVERITY IN INFLAMMATORY BOWEL DISEASE
9. Results of the 2nd scientific workshop of the ECCO (IV): Therapeutic strategies to enhance intestinal healing in inflammatory bowel disease
10. Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease
11. Leitlinienreport zu den aktualisierten S3-Leitlinien der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)
12. Results from the German registry for refractory celiac disease
13. Guideline Report on the updated S3-Guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM) Irritable Bowel Syndrome: Definition, Pathophysiology, Diagnosis and Therapy (June 2021 AWMF Registration Number: 021/016) and Intestinal Motility Disorders: Definition, Pathophysiology, Diagnosis, and Therapy ( June 2021-AWMF Registry Number: 021/018)
14. Leitlinie „Diagnostik und Therapie des Morbus Crohn“ – Kurzfassung für Internisten und Hausärzte
15. Schwere psoriatische Erythrodermie bei 22q11-Deletionssyndrom
16. Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM): Juni 2021 – AWMF-Registriernummer: 021-018
17. Konventionelle Diagnostik
18. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-κB decoy oligonucleotides
19. Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice—results of a non-representative survey
20. Accuracy of diagnostic tests and a new algorithm for diagnosing cytomegalovirus colitis in inflammatory bowel diseases: a diagnostic study
21. EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding
22. Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life
23. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease
24. Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease
25. Sa1294 Predictors for Subsequent Need for Immunosuppressive Therapy in Early Ulcerative Coltis
26. Psychological interventions for treatment of inflammatory bowel disease
27. Modulation of systemic antigen-specific immune responses by oral antigen in humans
28. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease
29. Kurzfassung der aktualisierten S3-Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und des Kompetenznetzes Darmerkrankungen zur Diagnostik und Behandlung des Morbus Crohn
30. Psychological interventions for treatment of inflammatory bowel disease
31. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
32. Aktuelle Therapie des Morbus Crohn.
33. Correction
34. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription
35. Characterization of the Catalytic Site of the ADP-Ribosyltransferase Clostridium botulinum C2 Toxin by Site-directed Mutagenesis
36. Gallbladder Involvement of Henoch-Schönlein Purpura Mimicking Acute Acalculous Cholecystitis.
37. Characterization of the Catalytic Site of the ADP-Ribosyltransferase Clostridium botulinumC2 Toxin by Site-directed Mutagenesis*
38. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.
39. Kapitel 4 - Konventionelle Diagnostik
40. Herausgeber und Autoren
41. Integrating the Patient Perspective to Validate a Measure of Disease Severity in Inflammatory Bowel Disease: Online Survey of Patients and Their Physicians.
42. Parameters of a severe disease course in ulcerative colitis.
43. [Clinical practice guideline on diagnosis and treatment of Crohn's disease - summary for the general practitioner].
44. [Severe erythrodermic psoriasis in a patient with 22q11 deletion syndrome].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.